**Core Concept**
Calcitonin is a hormone involved in calcium homeostasis, produced by the thyroid gland. It plays a crucial role in regulating calcium levels in the blood by inhibiting osteoclast activity, thereby reducing bone resorption.

**Why the Correct Answer is Right**
Calcitonin is used in conditions characterized by excessive bone resorption or elevated calcium levels. In hypervitaminosis D (A), excessive vitamin D leads to increased bone resorption, which calcitonin can help mitigate. Postmenopausal osteoporosis (B) involves bone loss due to estrogen deficiency, and calcitonin can help reduce bone resorption. Paget's disease (C) is a condition characterized by excessive bone resorption and remodeling, where calcitonin can help control bone resorption. However, Fanconi syndrome (D) is a disorder of renal tubular transport, characterized by impaired glucose, amino acid, and phosphate reabsorption, leading to hypophosphatemia and other electrolyte imbalances. Calcitonin would not be beneficial in this condition, as it can exacerbate hypophosphatemia.

**Why Each Wrong Option is Incorrect**
**Option A:** Hypervitaminosis D is a condition where excessive vitamin D leads to increased bone resorption, making calcitonin a suitable treatment.
**Option B:** Postmenopausal osteoporosis involves bone loss due to estrogen deficiency, where calcitonin can help reduce bone resorption.
**Option C:** Paget's disease is a condition characterized by excessive bone resorption and remodeling, where calcitonin can help control bone resorption.

**Clinical Pearl / High-Yield Fact**
Calcitonin is not suitable for conditions involving impaired renal phosphate reabsorption, such as Fanconi syndrome, as it can exacerbate hypophosphatemia.

**Correct Answer:**
✓ Correct Answer: D. Fanconi syndrome